GSA Capital Partners’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-4,330
| Closed | -$430K | – | 1899 |
|
|
2019
Q3 | $430K | Sell |
4,330
-9,821
| -69% | -$933K | 0.06% | 644 |
|
|
2019
Q2 | $1.31M | Buy |
+14,151
| New | +$1.34M | 0.15% | 133 |
|
|
2019
Q1 | – | Sell |
-16,500
| Closed | -$1.06M | – | 1863 |
|
|
2018
Q4 | $1.06M | Sell |
16,500
-9,260
| -36% | -$684K | 0.12% | 196 |
|
|
2018
Q3 | $2.31M | Buy |
25,760
+6,944
| +37% | +$614K | 0.13% | 181 |
|
|
2018
Q2 | $1.49M | Sell |
18,816
-6,247
| -25% | -$519K | 0.07% | 453 |
|
|
2018
Q1 | $2.24M | Sell |
25,063
-9,767
| -28% | -$938K | 0.12% | 225 |
|
|
2017
Q4 | $3.63M | Buy |
34,830
+25,433
| +271% | +$2.87M | 0.22% | 46 |
|
|
2017
Q3 | $1.37M | Buy |
+9,397
| New | +$1.28M | 0.09% | 325 |
|
|
2017
Q2 | – | Sell |
-12,715
| Closed | -$1.58M | – | 2156 |
|
|
2017
Q1 | $1.58M | Sell |
12,715
-483
| -4% | -$57.8K | 0.08% | 374 |
|
|
2016
Q4 | $1.53M | Sell |
13,198
-23,007
| -64% | -$2.56M | 0.09% | 322 |
|
|
2016
Q3 | $3.79M | Buy |
36,205
+20,156
| +126% | +$2.18M | 0.2% | 55 |
|
|
2016
Q2 | $1.58M | Sell |
16,049
-1,087
| -6% | -$112K | 0.09% | 352 |
|
|
2016
Q1 | $1.72M | Sell |
17,136
-7,224
| -30% | -$744K | 0.11% | 250 |
|
|
2015
Q4 | $2.92M | Sell |
24,360
-130,374
| -84% | -$15.1M | 0.14% | 133 |
|
|
2015
Q3 | $16.7M | Buy |
154,734
+131,027
| +553% | +$16.3M | 0.82% | 2 |
|
|
2015
Q2 | $2.74M | Sell |
23,707
-26,395
| -53% | -$3.02M | 0.11% | 200 |
|
|
2015
Q1 | $5.78M | Buy |
50,102
+37,787
| +307% | +$4.52M | 0.23% | 35 |
|
|
2014
Q4 | $1.38M | Sell |
12,315
-3,657
| -23% | -$386K | 0.1% | 288 |
|
|
2014
Q3 | $1.51M | Buy |
+15,972
| New | +$1.44M | 0.08% | 291 |
|
|
2014
Q2 | – | Sell |
-99,942
| Closed | -$6.98M | – | 2124 |
|
|
2014
Q1 | $6.98M | Buy |
99,942
+89,856
| +891% | +$7.12M | 0.5% | 19 |
|
|
2013
Q4 | $852K | Sell |
10,086
-11,556
| -53% | -$914K | 0.07% | 466 |
|
|
2013
Q3 | $1.67M | Buy |
21,642
+1,538
| +8% | +$108K | 0.13% | 155 |
|
|
2013
Q2 | $1.18M | Buy |
+20,104
| New | +$1.21M | 0.14% | 173 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
GSA Capital Partners's CELG Position: Q4 2019 in Review
GSA Capital Partners sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 4,330 shares — an estimated $430K sold.
GSA Capital Partners first reported a position in CELG in Q2 2013 and held it in 23 quarters. The position peaked at $16.7M in Q3 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- GSA Capital Partners reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- GSA Capital Partners sold 4,330 Celgene Corp shares in Q4 2019, an estimated $430K.
- GSA Capital Partners first reported a position in Celgene Corp in Q2 2013 and held it in 23 quarters.
- GSA Capital Partners's Celgene Corp position peaked at $16.7M in Q3 2015.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on GSA Capital Partners's 13F filing for Q4 2019, filed 12 Feb 2020.